Purchase Order 75N91018P00559

<p>The National Cancer Institute awarded a purchase order to New England Biolabs, Inc. for $10,680.00 on September 5, 2018, with an ultimate completion date of October 5, 2018. Performance occurs in Bethesda, Maryland. The order is a firm fixed price purchase of molecular biology products, reagents, and research supplies. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Nexome Genomics Inc. for $10,000.00 on July 2, 2018. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Work is scheduled for completion by August 2, 2018.</p>

<p>The National Human Genome Research Institute awarded a purchase order to New England Biolabs, Inc. for $10,494.90 on July 28, 2017. Performance occurs in North Bethesda, Maryland, with an ultimate completion date of August 27, 2017. The order is firm-fixed-price with no set-aside designation. The source does not specify the particular molecular biology products, reagents, or other supplies procured under this purchase order.</p>

<p>The National Cancer Institute issued a purchase order to Nexome Genomics Inc. for $12,250 on August 7, 2018. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of September 7, 2018. No small business set-aside applies.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $21,581.00 on August 28, 2018, with completion scheduled for September 28, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,621.46 on November 20, 2019, with an ultimate completion date of December 19, 2019. The order procures drugs and biologicals on a firm fixed-price basis. Place of performance is Grand Island, New York.</p>

<p>The National Cancer Institute awarded a purchase order to Nexome Genomics Inc. valued at $14,075.00 on November 30, 2018. Performance occurs in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of December 30, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to Eppendorf North America, Inc. for $12,841.60 on September 22, 2020, with completion on December 22, 2020. The order covers laboratory equipment on a firm fixed-price basis. Place of performance is Bethesda, Maryland.</p>